Action Steps for Employers Audit Pharmacy Spend: Evaluate current and projected GLP1 utilization within your health plan to quantify budget impact
In a recent study published in the Journal of Clinical Investigation , researchers reviewed the anti-inflammatory effects and mechanisms of glucagon-like peptide 1 (GLP-1)-based therapies
We are very satisfied with the sales growth in the first nine months of 2023, which is reflecting that more people than ever are benefiting from our innovative diabetes and obesity treatments, Novo Nordisk CEO Lars Fruergaard Jrgensen said in a statement
These effects can range from mild to severe
However, adverse effects may limit the treatment potential, e.g., glitazones are associated with phenotypical weight gain [136] and obeticholic acid induced pruritus and elevated LDL-C [137], the latter a potential concern in patients already at risk for cardiovascular disease
Unlike generic weight loss programs, we offer customized treatment plans to fit your bodys needs and goals